Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Oscar Health Inc (OSCR) vs Prospect Capital Corporation (PSEC) Price & Performance

Oscar Health IncTrade
Prospect Capital CorporationTrade

Price performance (Past 24H)

Key statistics

Oscar Health Inc vs Prospect Capital Corporation — how do they compare? Oscar Health Inc trades at $33.25 (market cap $10.22B), while Prospect Capital Corporation trades at $1.83 (market cap $974.22M). The key difference: Oscar Health Inc is far larger — about 10.5× Prospect Capital Corporation's market cap, and Prospect Capital Corporation pays a 23.01% dividend while Oscar Health Inc pays none. Which is the better fit depends on your goals — on Pluang, investors hold Oscar Health Inc for 15 Days and Prospect Capital Corporation for 78 Days on average.

OSCRPSEC
Market Cap
$10.22B$974.22M
Volume
4,123,3945,779,996
Sector
HealthFinancials
52-Week High
$33.81$3.05
52-Week Low
$10.85$1.82
Typical Hold Time
15 Days78 Days
Enterprise Value
$6.57B$2.73B
Dividend Yield
—23.01%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Oscar Health Inc

OSCR trades at $32.91, up 1.76% today, with a bullish technical outlook from moving averages and mixed oscillators. The stock shows strong revenue growth, with 2026 revenue projected at $15.3B, and profitability turning positive with a net income margin of 3.59%. Recent news highlights market share gains in the ACA sector and raised 2026 guidance, though Q3 2026 EPS is yet to be reported.

The outlook is positive with analyst consensus at Buy and a $34 price target, but risks include rising medical costs and execution challenges. Upside potential exists from scalable growth and margin expansion, yet volatility near resistance levels and competitive pressures warrant caution for investors.

Prospect Capital Corporation

PSEC trades at $1.84, up 0.55% with bearish technical signals despite recent earnings beats. The company shows inconsistent revenue trends with 2025 revenue at -$407M and net income of -$470M, though 2026 projections indicate recovery. Dividend payments continue at $0.04 monthly, while analyst sentiment remains mixed with 25% buy ratings amid concerns about NAV erosion and portfolio contraction.

PSEC presents high risk with volatile financial performance and bearish technical indicators. The 18%+ dividend yield appears unsustainable given negative cash flow and declining portfolio value. While current price represents a significant discount to book value, ongoing NAV erosion and mixed analyst consensus suggest cautious approach for investors seeking stability.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

OSCR

No sentiment data available yet.

PSEC
100% Buy0% Sell
Avg holding period · 78 Days

Top news

Latest headlines on both assets

About Oscar Health Inc

Oscar Health, Inc. is a health insurance company that utilizes a technology-driven approach to simplify the healthcare experience. The company offers individual, small-group, and Medicare Advantage plans, primarily through a platform that integrates technology, data, and design to provide members with a personalized, efficient healthcare journey. Oscar aims to lower costs and improve engagement by focusing on consumer-centricity and modernizing the traditional health insurance model.

Read more on OSCR →

About Prospect Capital Corporation

Prospect Capital Corp is a closed-end investment company based in the United States. Its investment objective is to generate both current income and long-term capital appreciation through debt and equity investments. The company invests primarily in senior and subordinated debt and equity of private companies for acquisitions, divestitures, growth, development, recapitalizations, and other purposes. It makes investments, including lending in private equity, sponsored transactions, directly to companies, investments in structured credit, real estate, and syndicated debt.

Read more on PSEC →